Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-01-01 @ 4:14 PM
Study NCT ID:
NCT04894266
Status:
TERMINATED
Last Update Posted:
2023-11-18
First Post:
2021-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Study of Apabetalone in Covid Infection
Sponsor:
Resverlogix Corp
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RVX222-CS-023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None